Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
Koo SH, Lee JS, Kim GH, Lee HG: Preparation, characteristics, and stability of glutathione-loaded nanoparticles
Since glutathione is a tripeptide (a small protein), the stomach often breaks it down into its individual amino acids before it can ever reach the cells
Multicenter and longitudinal studies are clearly needed to validate the potential of LC and ALC as novel biomarkers for MDD
Why is there no additional effect, even though it seems logical that there would be